Shekel Brainweigh Ltd

ASX:SBW ISIN:IL0011721474

Shekel Brainweigh LtdShekel Brainweigh Ltd (ASX:SBW) is a global leader in developing scale and weighing technology. The company provides weighing solutions to the highly regulated retail and healthcare markets via global giants such as G.E Healthcare, Toshiba, Fujitsu, Diebold Nixdorf and others.

Utilising its experience in weighing technology, Shekel Brainweigh has established its Retail Innovation Division, which is developing a suite of new products aimed at meeting the challenges that traditional retailers face today, such as store automation, operational efficiency including overstock and understock inventory issues and enhancing the consumer experience.

Shekel's patented combination of weighing technology with Artificial Intelligence (AI) and Internet of Things (IoT) technology has led to the development of its "Product Aware Technology". Shekel Brainweigh is committed to continuing to innovate and expand into global markets.

 
   

News

Shekel Brainweigh Ltd (ASX:SBW) On Track to Deliver 35% YoY Retail Revenue Growth in 2022

🕔12/15/2022 10:30:38 AM 1476

Shekel Brainweigh Ltd (ASX:SBW), an advanced weighing technology firm and artificial intelligence innovator, is pleased to provide an update on its 2022 sales results to the end of November 2022.

Read Full Article
###

834 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 22) (Since Published: 834) 

Company Data

    Headquarters
  • Kibbutz Beit Keshet 15247
    LOWER GALIL HEIGHTS
    ISRAEL
  • Telephone
  • +61-2-8098-1163 
  • Principal Sector
  • Industrial 
  • Principal Industry
  • Electronics & Equipment 
  • Homepage
  • www.shekelbrainweigh.com

More News Results

  • 2024/04/19: Notice of Annual General Meeting and Proxy Form*
  • 2024/04/17: Change of Chairman and CEO*
  • 2024/04/15: Response to ASX Query Letter*
  • 2024/04/02: Q1 2024 Shekel Brainweigh Business Update*
  • 2024/03/27: Appendix 4G and Corporate Governance Statement*
  • 2024/03/27: FY23 Annual Report and Consolidated Financial Statements*
  • 2024/03/27: Change of Director's Interest Notice*
  • 2024/03/26: Loan and Option Agreement Update*
  • 2024/02/28: FY23 Results Announcement*
  • 2024/02/28: Appendix 4E and Preliminary Final Report*
*refer to company website

Social Media